Are 23andMe's Cutbacks a Harbinger of Hard Times for DTC Genomics Firms?

The Mountain View, Calif.-based direct-to-consumer genomics firm has had a round of layoffs that it said were necessary to remain in business in a difficult economic climate. Competing DTC genomics firms have had cutbacks or are proceeding cautiously.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.